+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Antithrombin - Global Strategic Business Report - Product Thumbnail Image

Antithrombin - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Plasma Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Plasma Protein Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Delivery Systems for Repositioning IV Therapeutics - Product Thumbnail Image

Delivery Systems for Repositioning IV Therapeutics

  • Report
  • December 2021
  • 95 Pages
  • Global
Hemostats and Tissue Sealants - Global Strategic Business Report - Product Thumbnail Image

Hemostats and Tissue Sealants - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
From
Critical Care Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Critical Care Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 280 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • November 2024
  • 184 Pages
  • Global
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Viral Vector Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 250 Pages
  • Global
From
Subcutaneous Immunoglobulin - Global Strategic Business Report - Product Thumbnail Image

Subcutaneous Immunoglobulin - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
From
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
From
From
From
From
Loading Indicator